Determination of isoprostaglandin F2α type III in human urine by gas chromatography–electronic impact mass spectrometry. Comparison with enzyme immunoassay
- 1 April 2001
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 754 (2) , 333-343
- https://doi.org/10.1016/s0378-4347(00)00621-6
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Nomenclature of Isoprostanes: A ProposalPublished by Elsevier ,2003
- Streamlined F2-Isoprostane Analysis in Plasma and Urine with High-Performance Liquid Chromatography and Gas Chromatography/Mass SpectroscopyAnalytical Biochemistry, 2000
- Measurement of F2-isoprostanes as an index of oxidative stress in vivoFree Radical Biology & Medicine, 2000
- Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F 2 -isoprostanes in human urineProceedings of the National Academy of Sciences, 1999
- Increased 8-Isoprostane, a Marker of Oxidative Stress, in Exhaled Condensate of Asthma PatientsAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Increased CSF F 2 -isoprostane concentration in probable ADNeurology, 1999
- 8-Isoprostane as a Biomarker of Oxidative Stress in Interstitial Lung DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 1998
- A nomenclature system for the isoprostanesProstaglandins, 1997
- Increase in Circulating Products of Lipid Peroxidation (F2-Isoprostanes) in Smokers — Smoking as a Cause of Oxidative DamageNew England Journal of Medicine, 1995
- Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids.Proceedings of the National Academy of Sciences, 1992